Alan Healy

Alan Healy is an Assistant Professor of Chemistry at NYU Abu Dhabi, part of the NYU Global Network. He holds a BA (mod) in Medicinal Chemistry from Trinity College Dublin, an MSc in Biomedical Science from the University of Edinburgh, and a PhD in Chemistry from the University of St Andrews. His postdoctoral research at Yale University explored the relationship between gut bacteria toxins and colorectal cancer. Dr. Healy leads the Healy Lab, which focuses on integrating genomics, bioinformatics, and automated synthesis to discover natural products for drug development. His research emphasizes high-throughput screening and accessible synthetic platforms for global adoption.

Research interests include chemical biology, automated synthesis, and drug discovery. His lab develops state-of-the-art automated instrumentation to streamline natural product synthesis, aiming to bridge the gap between bioactive molecule discovery and preclinical drug candidates. Recent work highlights advancements in asymmetric catalysis, stereodivergent reactions, and structural elucidation of genotoxic agents like colibactin.

Teaching responsibilities include courses such as Organic Chemistry 2, Capstone Projects, and interdisciplinary modules like 'Panacea.' While no awards are explicitly listed, his contributions to colibactin structure determination and automated synthesis methodologies reflect impactful research. The Healy Lab fosters a multinational, inclusive environment, with a focus on translating fundamental chemistry into biomedical applications.